Investor Profile (AI Text)
Name: Noah Auerhahn
Canonical URL: https://wefunder.com/noah.auerhahn
Updated at: 2025-08-24T06:01:49Z

Description: See Noah Auerhahn's recent startup investments, sectors of interest, and updates. Follow their activity and discover companies on Wefunder.
Bio: CEO, Uncommon Therapeutics (YC W25), Developed a polytherapy to dramatically increase the quality of life for people with Rhett syndrome.
Follower count: 22

User claims:
- Bio: CEO, Uncommon Therapeutics (YC W25), Developed a polytherapy to dramatically increase the quality of life for people with Rhett syndrome.

Key claims:
- Follower count: 22 | citation: https://wefunder.com/noah.auerhahn#claim-user-follower-count

Verified facts:
- Follower count: 22 | observed_at: 2025-08-24T06:01:49Z | expires_at: 2025-08-25T06:01:49Z

Computed metrics:
- follower_count: 22
- recent_investment_count: 1
- recent_post_count: 0

Recent investments:
- S25 Orange Fund (2025-08-25T03:25:37Z) | citation: https://wefunder.com/noah.auerhahn#claim-user-investment-1